1 |
甜菊双糖苷晶型A、其制备方法、食品组合物及应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
2 |
醋酸曲安奈德晶型B、其制备方法、包含所述晶型B的药物组合物和用途
|
专利 |
梅雪锋;王建荣;朱冰清;鲍俊杰 |
3 |
Structure, physicochemical properties and pharmacokinetics of resveratrol and piperine cocrystals
|
期刊论文 |
He Hongyan;Zhang Qi;Wang Jian-Rong;Mei Xuefeng |
4 |
Mechanochromism triggered fluorescent color switching among polymorphs of a natural fluorescence pigment
|
期刊论文 |
Li Meiqi;Zhang Qi;Wang Jian-Rong;Mei Xuefeng |
5 |
Pharmaceutical cocrystals of the anti-tuberculosis drug pyrazinamide with dicarboxylic and tricarboxylic acids
|
期刊论文 |
Wang Jian-Rong;Ye Chanjuan;Zhu Bingqing;Zhou Chun;Mei Xuefeng |
6 |
Vapor triggered fluorescent color changes among solvates of Emodin
|
期刊论文 |
Li Meiqi;Zhang Qi;He Hongyan;Wang Jian-Rong;Mei Xuefeng |
7 |
A new polymorph of 1-hydroxy-2-naphthoic acid obtained during failed co-crystallization experiments
|
期刊论文 |
Zhang Qi;Li Meiqi;Mei Xuefeng |
8 |
吡咯并喹啉醌的二钠盐结晶
|
专利 |
朱理平;陆鹂烨;王建荣;孙琳琳;梅雪锋;顾建新 |
9 |
Selective crystallization of vitamin D3 for the preparation of novel conformational polymorphs with distinctive chemical stability
|
期刊论文 |
Wang Jian-Rong;Zhu Bingqing;Yu Qihui;Mei Xuefeng |
10 |
Improving the dissolution and bioavailability of 6-mercaptopurine via co-crystallization with isonicotinamide.
|
期刊论文 |
Wang Jian-Rong;Yu Xueping;Zhou Chun;Lin Yunfei;Chen Chen;Pan Guoyu;Mei Xuefeng |
11 |
制备高结晶度、粒径大的肌醇的结晶工艺及应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
12 |
一种淫羊藿苷H1晶型、其制法和其药物组合物与应用
|
专利 |
朱理平;梅雪锋;贾丽娜;王建荣;张奇 |
13 |
一种黄芩素γ晶型、其制法和其药物组合物与用途
|
专利 |
朱理平;梅雪锋;朱冰清;王建荣 |
14 |
一种黄芩苷A晶型、其制备方法及其应用
|
专利 |
朱理平;梅雪锋;王建荣;王晓娟;朱冰清 |
15 |
Polymorphism observed in dapsone-flavone cocrystals that present pronounced differences in solubility and stability
|
期刊论文 |
He Hongyan;Jiang Linglei;Zhang Qi;Huang Ying;Wang Jian-Rong;Mei Xuefeng |
16 |
Isostructurality in six celecoxib co-crystals introduced by solvent inclusion
|
期刊论文 |
Wang Xiaojuan;Zhang Qi;Jiang Linglei;Xu Yun;Mei Xuefeng |
17 |
Two New Polymorphs of Huperzine A Obtained from Different Dehydration Processes of One Monohydrate
|
期刊论文 |
Zhang Qi;Mei Xuefeng |
18 |
Drug-drug co-crystallization presents a new opportunity for the development of stable vitamins
|
期刊论文 |
Wang Jian-Rong;Yu Qihui;Dai Wenjuan;Mei Xuefeng |
19 |
甜菊糖C苷晶型V、其制备方法、食品组合物及应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
20 |
吡咯并喹啉醌的二钠盐结晶
|
专利 |
朱理平;陆鹂烨;王建荣;孙琳琳;梅雪锋;顾建新 |
21 |
一种淫羊藿苷Form α晶型、其制法和其药物组合物与应用
|
专利 |
朱理平;梅雪锋;贾丽娜;王建荣;张奇 |
22 |
固体药物的转晶现象
|
期刊论文 |
张奇;梅雪锋 |
23 |
pH-Switchable vitamin B9 gels for stoichiometry-controlled spherical co-crystallization.
|
期刊论文 |
Wang Jian-Rong;Bao Junjie;Fan Xiaowu;Dai Wenjuan;Mei Xuefeng |
24 |
一种淫羊藿苷H2晶型、其制法和其药物组合物与应用
|
专利 |
朱理平;梅雪锋;贾丽娜;王建荣;张奇 |
25 |
Insight into the Phase Transformation among Various Solid Forms of Baicalein
|
期刊论文 |
Zhu Bingqing;Wang Jian-Rong;Mei Xuefeng |
26 |
Absolute asymmetric synthesis of a sanguinarine derivative through crystal-solution interactions
|
期刊论文 |
Zhang Qi;Jia Lina;Wang Jian-Rong;Mei Xuefeng |
27 |
Determination of absolute configuration using heavy atom based co-crystallization method: Halogen atom effects
|
期刊论文 |
Wang Jian-Rong;Fan Xiaowu;Ding Qiaoce;Mei Xuefeng |
28 |
Taming photo-induced oxidation degradation of dihydropyridine drugs through cocrystallization.
|
期刊论文 |
Yu Qihui;Yan Zhicheng;Bao Junjie;Wang Jian-Rong;Mei Xuefeng |
29 |
甜菊糖B苷晶型G、其制备方法、食品组合物及应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
30 |
Improving Dissolution and Photostability of Vitamin K3 via Cocrystallization with Naphthoic Acids and Sulfamerazine
|
期刊论文 |
Zhu Bingqing;Wang Jian-Rong;Zhang Qi;Mei Xuefeng |
31 |
缬沙坦晶型E的诱导结晶工艺及应用
|
专利 |
朱理伟;梅雪锋;黄颖;王建荣 |
32 |
甜菊糖B苷钠盐晶型A、其制备方法、食品组合物及应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
33 |
吡咯并喹啉醌的二钠盐结晶
|
专利 |
朱理平;陆鹂烨;王建荣;孙琳琳;梅雪锋;顾建新 |
34 |
一种甜菊糖D苷晶型A、其制备方法及其应用
|
专利 |
朱理平;梅雪锋;黄颖;王建荣;张奇 |
35 |
Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan
|
期刊论文 |
Huang Ying;Zhang Qi;Wang Jian-Rong;Lin Kai-Lei;Mei Xuefeng |
36 |
Zwitterionic Cocrystals of Flavonoids and Proline: Solid-State Characterization, Pharmaceutical Properties, and Pharmacokinetic Performance
|
期刊论文 |
He Hongyan;Huang Ying;Zhang Qi;Wang Jian-Rong;Mei Xuefeng |
37 |
Solid-state characterization of 17 beta-estradiol co-crystals presenting improved dissolution and bioavailability
|
期刊论文 |
Wang Jian-Rong;Wang Xiaojuan;Yang Yong;Chen Xiaoyan;Mei Xuefeng |
38 |
Modulating the Dissolution and Mechanical Properties of Resveratrol by Cocrystallization
|
期刊论文 |
He Hongyan;Zhang Qi;Li Meiqi;Wang Jian-Rong;Mei Xuefeng |
39 |
替米沙坦与氢氯噻嗪的共晶
|
专利 |
王建荣 |
40 |
Versatile solid modifications of icariin: structure, properties and form transformation
|
期刊论文 |
Jia Lina;Zhang Qi;Wang Jian-Rong;Mei Xuefeng |
41 |
大黄素晶型Ι、其制备方法、药物组合物及应用
|
专利 |
朱理平;梅雪锋;李美琪;王建荣;张奇 |
42 |
Polymorphs and Hydrates of Apatinib Mesylate: Insight into the Crystal Structures, Properties, and Phase Transformations
|
期刊论文 |
Zhu Bin;Wang Jian-Rong;Ren Guobin;Mei Xuefeng |
43 |
甜菊糖M苷晶型及制备方法和用途
|
专利 |
朱理平;梅雪锋;黄颖;王建荣 |
44 |
Polymorphism of Triamcinolone Acetonide Acetate and Its Implication for the Morphology Stability of the Finished Drug Product
|
期刊论文 |
Wang Jian-Rong;Zhu Bingqing;Zhang Zaiyong;Bao Junjie;Deng Gaojin;Ding Qiaoce;Mei Xuefeng |
45 |
Cocrystals of Baicalein with Higher Solubility and Enhanced Bioavailability
|
期刊论文 |
Zhu Bingqing;Zhang Qj;Wang Jian-Rong;Mei Xuefeng |
46 |
Insight into the conformational polymorph transformation of a block-buster multiple sclerosis drug fingolimod hydrochloride (FTY 720)
|
期刊论文 |
Wang Jian-Rong;Li Sha;Zhu Bingqing;Mei Xuefeng |
47 |
Greener solid-state synthesis: stereo-selective [2+2] photodimerization of vitamin K-3 controlled by halogen bonding
|
期刊论文 |
Zhu Bingqing;Wang Jian-Rong;Zhang Qi;Mei Xuefeng |